Relation of Porphyria to Atrial Fibrillation

      Porphyrias are a group of inherited disorders affecting enzymes in the heme biosynthesis pathway, leading to overproduction and/or accumulation of porphyrin or its precursors. Porphyrias have been associated with autonomic dysfunction, which in turn can develop atrial fibrillation (AF). The purpose of this study was to characterize the prevalence of AF and atrial flutter (AFl) in patients with porphyrias. A single-center retrospective cohort study was designed using data from chart reviews of patients who were admitted to the hospital from January 2000 to June 2008. Fifty-six distinct cases were found with a discharge diagnosis of porphyria including all its subtypes. From the same database, age- and gender-matched controls were identified using computer-generated random numbers. We selected 1 age- and gender-matched control for each case. Electrocardiograms and echocardiograms were reviewed by 2 independent reviewers. Only patients with available 12-lead electrocardiograms that showed AF/AFl were labeled with that diagnosis. All patients with a diagnosis of porphyria were included in the study irrespective of their age. Seven of 56 patients with porphyria met inclusion criteria, yielding a prevalence of AF/AFl of 12.5%. This association was significant (p = 0.028, relative risk 7.45, 95% confidence interval 1.01 to 66.14) compared with the age- and gender-matched control group (2%). In conclusion, our observations suggest that porphyria may be significantly associated with AF/AFl.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gross U.
        • Hoffmann G.F.
        • Doss M.O.
        Erythropoietic and hepatic porphyrias.
        J Inherit Metab Dis. 2000; 23: 641-661
        • Thadani H.
        • Deacon A.
        • Peters T.
        Diagnosis and management of porphyria.
        BMJ. 2000; 320: 1647-1651
        • Anderson K.E.
        • Bloomer J.R.
        • Bonkovsky H.L.
        • Kushner J.P.
        • Pierach C.A.
        • Pimstone N.R.
        • Desnick R.J.
        Recommendations for the diagnosis and treatment of the acute porphyrias.
        Ann Intern Med. 2005; 142: 439-450
        • Blom H.
        • Andersson C.
        • Olofsson B.O.
        • Bjerle P.
        • Wiklund U.
        • Lithner F.
        Assessment of autonomic nerve function in acute intermittent porphyria; a study based on spectral analysis of heart rate variability.
        J Intern Med. 1996; 240: 73-79
        • Jahangir A.
        • Hammill S.C.
        Parasympathetics and atrial fibrillation.
        J Cardiovasc Electrophysiol. 2005; 16: 885-887
        • Gupta G.L.
        • Saksena H.C.
        • Gupta B.D.
        Cardiac dysautonomia in acute intermittent porphyria.
        Indian J Med Res. 1983; 78: 253-256
        • Gupta G.L.
        • Saksena H.C.
        • Gupta B.D.
        Autonomic neuropathy and hypertension in acute intermittent porphyria.
        J Assoc Phys India. 1983; 31: 259
        • Leonhardt K.F.
        Cardiovascular disorders in acute intermittent porphyria (AIP) (author's translation).
        Wien Klin Wochenschr. 1981; 93: 580-584
        • Tilbery C.P.
        • Sanvito W.L.
        • Espindola E.S.
        Dysautonomic aspects of acute intermittent porphyria.
        Arq Neuropsiquiatr. 1979; 37: 151-157
        • Ridley A.
        • Hierons R.
        • Cavanagh J.B.
        Tachycardia and the neuropathy of porphyria.
        Lancet. 1968; 2: 708-710
        • Berlin L.
        • Cotton R.
        Gastro-intestinal manifestations of porphyria.
        Am J Digest Dis. 1950; 17: 110-114
        • Stein J.A.
        • Tschudy D.P.
        Acute intermittent porphyria: a clinical and biochemical study of 46 patients.
        Medicine (Baltimore). 1970; 49: 1-16
        • Yeung Laiwah A.C.
        • Goldberg A.
        • Moore M.R.
        Pathogenesis and treatment of acute intermittent porphyria: discussion paper.
        J R Soc Med. 1983; 76: 386-392
        • Maines M.D.
        New development in the regulation of heme metabolism and their implication.
        in: Goldberg L. Critical Reviews in Toxicology. Volume 12. CRC Press, Boca Raton, Florida, Florida1984: 241-313
        • Benjamin E.J.
        • Wolf P.A.
        • D'Agostino R.B.
        • Silbershatz H.
        • Kannel W.B.
        • Levy D.
        Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
        Circulation. 1998; 98: 946
        • Chugh S.S.
        • Blackshear J.L.
        • Shen W.K.
        • Hammill S.C.
        • Gersh B.J.
        Epidemiology and natural history of atrial fibrillation: clinical implications.
        J Am Coll Cardiol. 2001; 37: 371
        • Go A.S.
        • Hylek E.M.
        • Phillips K.A.
        • Chang Y.
        • Henault L.E.
        • Selby J.V.
        • Singer D.E.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
        JAMA. 2001; 285: 2370-2375